Dr. Majety is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Avenue
Boston, MA 02115
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2020 - 2022
Tufts Medical CenterResidency, Internal Medicine, 2017 - 2020
Sri Devaraj URS Medical CollegeClass of 2016
Certifications & Licensure
VA State Medical License 2022 - 2026
MA State Medical License 2017 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- A Case of Refractory Thyroid Storm Despite Correction of Peripheral Thyroid Hormone Levels.Madeline Evans, Grace Prince, Priyanka Majety
JCEM Case Reports. 2024-10-01 - 11 citationsEfficacy and safety of tirzepatide, GLP-1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta-analysis.Xin-Hui Pan, Bryan Tan, Yip Han Chin, Ethan Cheng Zhe Lee, Gwyneth Kong
Obesity. 2024-05-01 - Liver and cardiovascular disease outcomes in metabolic syndrome and diabetic populations: Bi-directional opportunities to multiply preventive strategies.Alhussain Yasin, Madison Nguyen, Angad Sidhu, Priyanka Majety, Jared Spitz
Diabetes Research and Clinical Practice. 2024-05-01
Press Mentions
Endocrinologists Give Health Care Tips for Diabetes Prevention MonthNovember 7th, 2024- Tirzepatide, Semaglutide More Efficacious Than Other FDA-Approved Drugs for Weight LossOctober 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
